SYK and systemic lupus erythematosus: With Syk inhibitor, lupus characteristics and systemic inflammation in FcγRIIb−/− mice were less prominent than the mice without inhibitor, as indicated by serum anti-dsDNA, proteinuria, and serum cytokines (TNFa but not IL-6) (Fig. 1C-F).